Literature DB >> 25772134

Engineering Stem Cells for Biomedical Applications.

Perry T Yin1, Edward Han2, Ki-Bum Lee1,3.   

Abstract

Stem cells are characterized by a number of useful properties, including their ability to migrate, differentiate, and secrete a variety of therapeutic molecules such as immunomodulatory factors. As such, numerous pre-clinical and clinical studies have utilized stem cell-based therapies and demonstrated their tremendous potential for the treatment of various human diseases and disorders. Recently, efforts have focused on engineering stem cells in order to further enhance their innate abilities as well as to confer them with new functionalities, which can then be used in various biomedical applications. These engineered stem cells can take on a number of forms. For instance, engineered stem cells encompass the genetic modification of stem cells as well as the use of stem cells for gene delivery, nanoparticle loading and delivery, and even small molecule drug delivery. The present Review gives an in-depth account of the current status of engineered stem cells, including potential cell sources, the most common methods used to engineer stem cells, and the utilization of engineered stem cells in various biomedical applications, with a particular focus on tissue regeneration, the treatment of immunodeficiency diseases, and cancer.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  engineered stem cells; gene therapy; multifunctional nanoparticles; nanomedicine; regenerative medicine; stem cell therapy

Mesh:

Year:  2015        PMID: 25772134      PMCID: PMC5810416          DOI: 10.1002/adhm.201400842

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN: 2192-2640            Impact factor:   9.933


  387 in total

1.  Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study.

Authors:  Marjolijn Duijvestein; Anne Christine W Vos; Helene Roelofs; Manon E Wildenberg; Barbara B Wendrich; Henricus W Verspaget; Engelina M C Kooy-Winkelaar; Frits Koning; Jaap Jan Zwaginga; Herma H Fidder; Auke P Verhaar; Willem E Fibbe; Gijs R van den Brink; Daniel W Hommes
Journal:  Gut       Date:  2010-10-04       Impact factor: 23.059

2.  Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma.

Authors:  Mariam A Stoff-Khalili; Angel A Rivera; J Michael Mathis; N Sanjib Banerjee; Amanda S Moon; A Hess; Rodney P Rocconi; T Michael Numnum; M Everts; Louise T Chow; Joanne T Douglas; Gene P Siegal; Zeng B Zhu; Hans Georg Bender; Peter Dall; Alexander Stoff; Larissa Pereboeva; David T Curiel
Journal:  Breast Cancer Res Treat       Date:  2007-01-13       Impact factor: 4.872

3.  WASP confers selective advantage for specific hematopoietic cell populations and serves a unique role in marginal zone B-cell homeostasis and function.

Authors:  Lisa S Westerberg; Miguel A de la Fuente; Fredrik Wermeling; Hans D Ochs; Mikael C I Karlsson; Scott B Snapper; Luigi D Notarangelo
Journal:  Blood       Date:  2008-09-04       Impact factor: 22.113

4.  Multimodal magnetic core-shell nanoparticles for effective stem-cell differentiation and imaging.

Authors:  Birju Shah; Perry T Yin; Shraboni Ghoshal; Ki-Bum Lee
Journal:  Angew Chem Int Ed Engl       Date:  2013-05-06       Impact factor: 15.336

5.  "Same day" ex-vivo regional gene therapy: a novel strategy to enhance bone repair.

Authors:  Mandeep S Virk; Osamu Sugiyama; Sang H Park; Sanjiv S Gambhir; Douglas J Adams; Hicham Drissi; Jay R Lieberman
Journal:  Mol Ther       Date:  2011-02-22       Impact factor: 11.454

6.  Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia.

Authors:  Marina Cavazzana-Calvo; Emmanuel Payen; Olivier Negre; Gary Wang; Kathleen Hehir; Floriane Fusil; Julian Down; Maria Denaro; Troy Brady; Karen Westerman; Resy Cavallesco; Beatrix Gillet-Legrand; Laure Caccavelli; Riccardo Sgarra; Leila Maouche-Chrétien; Françoise Bernaudin; Robert Girot; Ronald Dorazio; Geert-Jan Mulder; Axel Polack; Arthur Bank; Jean Soulier; Jérôme Larghero; Nabil Kabbara; Bruno Dalle; Bernard Gourmel; Gérard Socie; Stany Chrétien; Nathalie Cartier; Patrick Aubourg; Alain Fischer; Kenneth Cornetta; Frédéric Galacteros; Yves Beuzard; Eliane Gluckman; Frederick Bushman; Salima Hacein-Bey-Abina; Philippe Leboulch
Journal:  Nature       Date:  2010-09-16       Impact factor: 49.962

7.  Therapeutic potential of angiogenin modified mesenchymal stem cells: angiogenin improves mesenchymal stem cells survival under hypoxia and enhances vasculogenesis in myocardial infarction.

Authors:  Xiao-Hong Liu; Chen-Guang Bai; Zhi-Yun Xu; Sheng-Dong Huang; Yang Yuan; De-Jun Gong; Jian-Rong Zhang
Journal:  Microvasc Res       Date:  2008-03-18       Impact factor: 3.514

8.  Adenoviral-mediated interleukin-18 expression in mesenchymal stem cells effectively suppresses the growth of glioma in rats.

Authors:  Gang Xu; Xiao-Dan Jiang; Ying Xu; Jing Zhang; Fan-Heng Huang; Zhen-Zhou Chen; De-Xiang Zhou; Jiang-Hua Shang; Yu-Xi Zou; Ying-Qian Cai; Sheng-Bin Kou; Yi-Zhao Chen; Ru-Xiang Xu; Yan-Jun Zeng
Journal:  Cell Biol Int       Date:  2008-08-06       Impact factor: 3.612

9.  Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia.

Authors:  Toshiyuki Onda; Osamu Honmou; Kuniaki Harada; Kiyohiro Houkin; Hirofumi Hamada; Jeffery D Kocsis
Journal:  J Cereb Blood Flow Metab       Date:  2007-07-18       Impact factor: 6.200

10.  Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration.

Authors:  Eugenio Montini; Daniela Cesana; Manfred Schmidt; Francesca Sanvito; Maurilio Ponzoni; Cynthia Bartholomae; Lucia Sergi Sergi; Fabrizio Benedicenti; Alessandro Ambrosi; Clelia Di Serio; Claudio Doglioni; Christof von Kalle; Luigi Naldini
Journal:  Nat Biotechnol       Date:  2006-05-28       Impact factor: 54.908

View more
  6 in total

1.  Stem Cell Extracellular Vesicles and their Potential to Contribute to the Repair of Damaged CNS Cells.

Authors:  Heather Branscome; Siddhartha Paul; Pooja Khatkar; Yuriy Kim; Robert A Barclay; Daniel O Pinto; Dezhong Yin; Weidong Zhou; Lance A Liotta; Nazira El-Hage; Fatah Kashanchi
Journal:  J Neuroimmune Pharmacol       Date:  2019-07-24       Impact factor: 4.147

2.  A Single-Cell Raman Spectroscopy Analysis of Bone Marrow Mesenchymal Stem/Stromal Cells to Identify Inter-Individual Diversity.

Authors:  Tamara Kukolj; Jasmina Lazarević; Ana Borojević; Uroš Ralević; Dragana Vujić; Aleksandra Jauković; Nenad Lazarević; Diana Bugarski
Journal:  Int J Mol Sci       Date:  2022-04-28       Impact factor: 6.208

Review 3.  The Clinical Status of Stem Cell Therapy for Ischemic Cardiomyopathy.

Authors:  Xianyun Wang; Jun Zhang; Fan Zhang; Jing Li; Yaqi Li; Zirui Tan; Jie Hu; Yixin Qi; Quanhai Li; Baoyong Yan
Journal:  Stem Cells Int       Date:  2015-05-26       Impact factor: 5.443

Review 4.  NADPH Oxidases: Insights into Selected Functions and Mechanisms of Action in Cancer and Stem Cells.

Authors:  Magdalena Skonieczna; Tomasz Hejmo; Aleksandra Poterala-Hejmo; Artur Cieslar-Pobuda; Rafal J Buldak
Journal:  Oxid Med Cell Longev       Date:  2017-05-23       Impact factor: 6.543

5.  Insulin-like growth factor-II overexpression accelerates parthenogenetic stem cell differentiation into cardiomyocytes and improves cardiac function after acute myocardial infarction in mice.

Authors:  Yi Sui; Wei Zhang; Tao Tang; Lili Gao; Ting Cao; Hongbo Zhu; Qinghua You; Bo Yu; Tao Yang
Journal:  Stem Cell Res Ther       Date:  2020-02-26       Impact factor: 6.832

Review 6.  Stem Cell Therapies: A Way to Promising Cures.

Authors:  Khalid Nawab; Deepak Bhere; Anthony Bommarito; Muhammad Mufti; Awais Naeem
Journal:  Cureus       Date:  2019-09-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.